CoVis – Discover reliable COVID-19 research

“For the development of therapeutics and vaccines for COVID-19, scientists depend on reliable research results. To support them, Open Knowledge Maps and ReFigure have launched CoVis: a curated knowledge map of seminal works on COVID-19 from eight critical areas of biomedical research. The knowledge map is constantly evolving thanks to the collective editing of subject-matter experts.

CoVis enables you to spend less time reviewing coronavirus literature and more time on your research….

Unless otherwise noted, all content on CoVis is licensed under a Creative Commons Attribution 4.0 International License. The CoVis database is made available under CC0 (Public Domain Dedication). Our software is open source and hosted on Github….”

CoVis – Discover reliable COVID-19 research

“For the development of therapeutics and vaccines for COVID-19, scientists depend on reliable research results. To support them, Open Knowledge Maps and ReFigure have launched CoVis: a curated knowledge map of seminal works on COVID-19 from eight critical areas of biomedical research. The knowledge map is constantly evolving thanks to the collective editing of subject-matter experts.

CoVis enables you to spend less time reviewing coronavirus literature and more time on your research….

Unless otherwise noted, all content on CoVis is licensed under a Creative Commons Attribution 4.0 International License. The CoVis database is made available under CC0 (Public Domain Dedication). Our software is open source and hosted on Github….”

CoVis: a new tool to discover reliable COVID-19 research | Labs | eLife

“For the development of therapeutics and vaccines for COVID-19, scientists depend on validated knowledge on the coronavirus. But finding reliable research results is often difficult: with over 20,000 papers published on the topic in the last six months, scientists spend a lot of valuable time finding, reading and reviewing the literature.

CoVis is a new tool that enables scientists to kick-start their COVID-19 research. In this EU-funded project, experts compile seminal research in a freely accessible database. The resulting data is fed into a knowledge map, providing a quick and intuitive overview of the collected research output. Often key findings are addressed and substantiated by multiple research sources. In such cases, data and images from different sources are compiled into a visual dashboard called a ReFigure, to help readers quickly understand the various facets of the research topic….

CoVis is an open infrastructure following the principles of open science, and can therefore be fully reused. Content on CoVis is licensed under CC BY 4.0. The CoVis database is made available under CC0. Our software is open source and hosted on GitHub under the MIT license….”

CoVis: a new tool to discover reliable COVID-19 research | Labs | eLife

“For the development of therapeutics and vaccines for COVID-19, scientists depend on validated knowledge on the coronavirus. But finding reliable research results is often difficult: with over 20,000 papers published on the topic in the last six months, scientists spend a lot of valuable time finding, reading and reviewing the literature.

CoVis is a new tool that enables scientists to kick-start their COVID-19 research. In this EU-funded project, experts compile seminal research in a freely accessible database. The resulting data is fed into a knowledge map, providing a quick and intuitive overview of the collected research output. Often key findings are addressed and substantiated by multiple research sources. In such cases, data and images from different sources are compiled into a visual dashboard called a ReFigure, to help readers quickly understand the various facets of the research topic….

CoVis is an open infrastructure following the principles of open science, and can therefore be fully reused. Content on CoVis is licensed under CC BY 4.0. The CoVis database is made available under CC0. Our software is open source and hosted on GitHub under the MIT license….”

Welcome to GLAM 3D | GLAM 3D Engelberg Center

“If you are thinking about starting a 3D Open Access program you have come to the right place!

This site will walk you through the entire process of planning, creating, and launching an Open Access 3D scanning program. It is designed to have something for everyone, from 3D beginners to 3D experts.

Glam3D.org is an open resource that welcomes contributions and suggestions from the community.”

 

Ten simple rules for innovative dissemination of research

“How we communicate research is changing because of new (especially digital) possibilities. This article sets out 10 easy steps researchers can take to disseminate their work in novel and engaging ways, and hence increase the impact of their research on science and society….”

 

Ten simple rules for innovative dissemination of research

“How we communicate research is changing because of new (especially digital) possibilities. This article sets out 10 easy steps researchers can take to disseminate their work in novel and engaging ways, and hence increase the impact of their research on science and society….”

 

New NIH Resource to Analyze COVID-19 Literature: The COVID-19 Portfolio Tool | NIH Extramural Nexus

“In the past few months, the scientific community has ramped up research in response to the SARS?CoV?2 pandemic; dozens of peer-reviewed articles and preprints on this topic are being added to the literature every day (Figure 1). This rapidly expanding effort has created challenges for scientists and the medical community who need to analyze thousands of scholarly articles for insights on the virus.

Recently, the National Library of Medicine at NIH joined the White House and key industry and university leaders to release the COVID-19 Research Dataset (CORD-19) and call on the AI community to develop text mining tools that help analyze and summarize the over 45,000 coronavirus articles. The CORD-19 dataset represents the most comprehensive, freely available library of machine readable coronavirus scholarly literature to date, with hundreds of AI tools and technologies already created.  

Building on this effort, the NIH Office of Portfolio Analysis (OPA) has assembled a comprehensive listing of COVID?19 publications and preprints that is freely available to the public and coupled with a user-friendly portfolio analysis interface for querying the full text and supplemental data. The COVID-19 portfolio is updated daily with new literature selected for inclusion by subject matter experts.  It draws upon NLM’s PubMed resource for citations and abstracts of published biomedical literature….”